Mary G Sorci-Thomas

Plain English
This study looked at how a special peptide called D-4F can help restore blood vessel growth in hearts affected by high cholesterol. When tested on mice with high cholesterol, D-4F reduced harmful properties of HDL cholesterol and improved heart function, showing a 21% decrease in heart tissue damage and better blood flow stimulation. This finding is important because it suggests a potential treatment to help patients with ischemic heart disease who have high cholesterol levels. Who this helps: This helps patients with heart disease and high cholesterol.

Plain English
This study looked at a protein called PCPE2, which plays various roles in cells and is found outside of them. Researchers found that PCPE2 is linked to many different cell types and biological processes, rather than just helping with collagen, as was previously thought. For example, it appears in different amounts in various tissues and is often associated with important cellular activities related to disease. Who this helps: This benefits researchers and medical professionals studying cell function and disease mechanisms.

Plain English
This study explored how a type of cholesterol known as high-density lipoprotein (nHDL) affects the growth of new blood vessels, a process called angiogenesis. Researchers found that normal HDL can lower levels of a molecule called HDRACA in cells, which helps promote blood vessel growth. However, HDL from patients with heart disease (dHDL) did not lower HDRACA levels as effectively, meaning it can't support blood vessel growth as well. This is important because understanding how these two types of HDL work can help improve treatments for patients with heart disease. Who this helps: This benefits patients with heart disease.

Plain English
This study looked at how certain proteins inside liver cells affect the production of harmful cholesterol particles in the bloodstream. Researchers discovered that a protein called tPA can attach to another protein called apoB, which helps prevent the creation of very-low-density lipoproteins (VLDL). The presence of a different protein, PAI-1, interferes with this process, leading to higher levels of VLDL and cholesterol. Specifically, people lacking PAI-1 have smaller VLDL particles and lower cholesterol levels. Who this helps: This research benefits patients at risk of heart disease by providing insights into potential treatments.

Plain English
This study looked at how a specific protein called scavenger receptor class B type I (SR-BI) affects how fat cells, known as adipocytes, take in glucose and manage energy. The researchers found that when SR-BI was missing, the fat cells could not efficiently absorb glucose, resulting in less effective energy use and more fat storage; for instance, the ability to process glucose was notably decreased in these fat cells. This is important because understanding how glucose uptake works in fat cells can help address problems related to obesity and related diseases like diabetes. Who this helps: This helps patients struggling with obesity and related metabolic disorders.

Plain English
This research looks at how a protein called apolipoprotein A-I (apoA-I) interacts with another protein, ABCA1, to help remove excess cholesterol from cells. The study highlights that specific parts of apoA-I are crucial for effectively processing cholesterol and forming new HDL particles, which are important for heart health. Understanding these processes can lead to better treatments for heart disease, as HDL helps prevent the buildup of cholesterol in arteries. Who this helps: This benefits patients at risk for heart disease.

Plain English
This study examined how a protein called adiponectin helps move cholesterol out of cells, a process involving another protein, apolipoprotein A-I (apoA-I). The researchers found that specific parts of the apoA-I protein, from residues 187 to 243, are necessary for adiponectin to effectively promote cholesterol movement from certain immune cells and kidney cells. This is important because understanding this mechanism could help develop treatments for heart disease linked to cholesterol buildup. Who this helps: This research benefits patients at risk of heart disease, as it highlights potential targets for cholesterol management.

Plain English
This study looked at how changes in certain proteins affect the lymphatic system, which helps transport fluids in the body and is important in preventing heart disease. The researchers found that low-density lipoprotein receptors (LDLR) in lymphatic cells play a key role: when LDLR levels were reduced, the lymphatic function worsened, and the ability of lymph vessels to contract was significantly reduced. By using a specific treatment in mice, they were able to delay heart disease progression linked to these lymphatic issues. Who this helps: This research helps patients at risk for heart disease by highlighting potential treatments to improve lymphatic function.

Plain English
This research focused on a protein called Rap1 and its role in preventing the progression of a disease called atherosclerosis, which involves plaque buildup in the arteries. The study found that when Rap1 was removed from certain cells in mice, plaque formation increased significantly, with about 50% larger plaque areas and more inflammation in the blood vessels compared to normal conditions. This is important because it highlights how Rap1 helps maintain healthy blood vessel function and could lead to new ways to treat or prevent heart disease. Who this helps: This helps patients at risk for heart disease and doctors treating them.

Plain English
This study looked at how high-density lipoprotein (HDL) made in the intestines helps protect the liver from damage. The researchers found that when HDL levels from the intestine were low, liver injury worsened in mice, while treatments that increased intestinal HDL improved liver health. This matters because it highlights that HDL from the gut plays a crucial role in reducing liver inflammation and damage. Who this helps: This helps patients with liver conditions and their doctors by providing insights into potential treatments.

Plain English
Researchers studied a protein called Pcpe2 and its role in helping fat cells take in good cholesterol (HDL). They found that when this protein was absent in mice, the fat cells had more of a receptor (SR-BI) but took in much less cholesterol—up to 75% less—leading to a reduction in overall fat tissue despite higher levels of fat in the blood. This is important because understanding how Pcpe2 regulates cholesterol uptake can help in managing conditions like heart disease and obesity. Who this helps: This benefits patients at risk of heart disease and obesity.

Plain English
This study looked at how blocking an enzyme called myeloperoxidase affects plaque psoriasis, a common skin condition that causes red and flaky patches. Researchers tested this idea using a cream on mice with psoriasis and found that inhibiting myeloperoxidase reduced the severity of their skin lesions, suggesting that oxidative damage plays a role in the condition. This is important because it opens up new possibilities for more effective treatments for people suffering from plaque psoriasis. Who this helps: Patients with plaque psoriasis.

Plain English
Researchers looked at how genetic differences affect cholesterol levels by combining data from mice and humans. They found 54 important genes related to cholesterol and fat metabolism, with one gene called Sestrin1 being particularly linked to higher cholesterol levels. Understanding these genes helps us grasp the biological processes behind cholesterol management, which is crucial for tackling heart disease. Who this helps: This helps patients at risk for heart disease and doctors treating cholesterol-related conditions.

Plain English
This research paper examines special areas in cell membranes called lipid rafts, which play a crucial role in how cells communicate and organize themselves. The study highlights that these rafts are important for transporting materials within the cell and may be linked to diseases like atherosclerosis when they don't work properly. Understanding lipid rafts better could lead to new treatments for cardiovascular diseases and improve our knowledge of cell function. Who this helps: Patients with cardiovascular diseases and other related conditions.

Plain English
This study looked at how a specific immune protein called interleukin-17 (IL-17) affects the movement of cholesterol-carrying particles (lipoproteins) in the skin and arteries of mice with a skin condition known as psoriasis. Researchers found that IL-17 causes changes in the tissue, making it harder for these lipoproteins to move freely, which could lead to increased risk of heart disease; specifically, they observed that blocking IL-17 helped restore normal movement of these particles and reduce stiffness in blood vessels. This matters because it highlights a potential way to prevent heart problems in people with psoriasis. Who this helps: Patients with psoriasis and related cardiovascular issues.

Plain English
This study looked at how a protein called LCAT that helps HDL (good cholesterol) works in patients with acute coronary syndrome, a serious heart condition. Researchers found that LCAT levels dropped significantly during heart attacks, leading to HDL losing its ability to help blood vessels make nitric oxide, which is important for heart health. When they added a form of LCAT in tests, it successfully restored HDL's helpful functions, indicating that targeting LCAT might be a new way to improve treatments for heart patients. Who this helps: Patients with acute coronary syndrome.

Plain English
The HDL Workshop brought together scientists and researchers to discuss high-density lipoprotein (HDL) and its impact on heart health during its ninth meeting in May 2019. Researchers presented findings on HDL's role in blood vessel health, its complexity, and how it interacts with gut bacteria, highlighting the need for more exploration of HDL's benefits. This research is important because it helps deepen our understanding of heart disease and promotes new approaches to prevention and treatment. Who this helps: Patients at risk of cardiovascular disease.

Plain English
This study looked at how high-density lipoprotein (HDL), often referred to as "good cholesterol," can help prevent the buildup of harmful cholesterol in arteries, which leads to heart disease. Researchers found that measuring the function of HDL—in particular, its ability to remove cholesterol from cells—might be a better indicator of heart disease risk than just checking HDL levels in the blood. Understanding how HDL works may lead to better treatments, focusing not just on increasing HDL levels but on enhancing its effectiveness in removing cholesterol. Who this helps: This helps patients at risk of cardiovascular disease.

Plain English
This study looked at how certain immune cells, known as regulatory T cells (Treg), change during the development of atherosclerosis, a condition where arteries become clogged with fat. Researchers found that Treg cells can switch to a different type of immune cell, T follicular helper cells (Tfh), which actually promote atherosclerosis. Specifically, when they prevented this switch by injecting a protein called Apolipoprotein AI (ApoAI), they reduced the buildup of fat in arteries. This finding is important because it suggests that ApoAI could help stop the progression of atherosclerosis by keeping immune cells in their protective form. Who this helps: This helps patients at risk of cardiovascular diseases.

Plain English
This study looked at how a molecule called sphingosine 1-phosphate (S1P), which is carried by high-density lipoprotein (HDL), interacts with specific cell receptors in the body to influence cell activity. Researchers found that when HDL is present, it helps the SR-BI receptor connect with the S1PR1 receptor, leading to an increase in calcium levels inside cells. Specifically, they noted that the presence of S1P in HDL causes SR-BI and S1PR1 to work together, which is important for signaling in vascular cells. Who this helps: This research benefits patients with cardiovascular issues by improving understanding of how HDL impacts heart and vascular function.

Plain English
This study looked at how temperature affects heart health and the movement of blood cells related to inflammation. Researchers found that keeping mice at a comfortable temperature (thermoneutrality) reduced the number of monocytes (a type of white blood cell) in their blood, which can help prevent plaque buildup in the arteries. In contrast, having low levels of a protein called UCP1 didn’t have the same effect on monocyte movement; rather, it led to other health issues like poor sugar control. This matters because it suggests that maintaining a moderate temperature can be important for heart health by keeping inflammation in check. Who this helps: This helps patients at risk for cardiovascular diseases and healthcare providers looking to improve treatment strategies.

Plain English
This study focused on a protein called apolipoprotein A-I (apoA-I), which plays a key role in the structure and function of healthy cholesterol (HDL). Researchers created a detailed model of apoA-I in its unbound state using various scientific techniques, and they found that this model aligns with data collected over the past 40 years. Understanding this model is important because it helps clarify how HDL is formed and how it protects against heart disease. Who this helps: This helps patients at risk of heart disease and doctors treating them.

Plain English
This study focused on how cholesterol levels in the blood affect immune cells and contribute to the development of atherosclerosis, a condition where arteries harden due to plaque buildup. Researchers found that too much cholesterol leads to the accumulation of harmful substances in immune cells, which can cause inflammation. Specifically, they highlighted that managing the balance of different forms of cholesterol is crucial for keeping immune cell activity in check and preventing artery problems. Who this helps: This helps patients at risk of heart disease and doctors treating them.

Plain English
Researchers studied how a specific protein, apolipoprotein A-I (apoA-I), helps form high-density lipoprotein (HDL), which is important for removing cholesterol from cells. They found that the ends of the apoA-I protein play significant roles in gathering lipids, while the central part of the protein needs to open up for HDL particles to form properly. This research matters because understanding how HDL is created could lead to better treatments for high cholesterol levels, which is a risk factor for heart disease. Who this helps: This benefits patients with high cholesterol and heart disease.

Plain English
This study looked at how a treatment using a type of protein called lipid-free apolipoprotein A-I (apoA-I) can help reduce the buildup of fats and immune cells in the arteries of mice fed a high-fat diet, which can lead to a condition called atherosclerosis. After six weeks of treatment with apoA-I, the mice showed a significant decrease in fat deposits and immune cell presence in their arteries compared to control mice, with a reduction of 25% in cholesterol accumulation. This is important because it indicates that apoA-I can help manage atherosclerosis without needing to significantly increase good cholesterol levels in the blood. Who this helps: This benefits patients at risk for heart disease, especially those with high cholesterol.

Plain English
This study looked at how a specific protein called apoAI, produced by immune cells called macrophages, helps protect against diseases related to high cholesterol, like skin issues (dermatitis) and hardening of the arteries (atherosclerosis). The researchers found that mice with increased levels of macrophage apoAI had 39.8% fewer CD4+ T-cells in their arteries and skin, leading to 25% smaller lesions and improved skin health without changing their overall HDL cholesterol levels. This is important because it shows that targeting macrophage apoAI could provide a way to fight cholesterol-related diseases without altering traditional cholesterol levels. Who this helps: This research benefits patients at risk for heart disease and skin conditions linked to high cholesterol.

Plain English
This study looked at a protein called PCPE2 and its role in reducing the risk of atherosclerosis (buildup of fats in arteries) in mice. Researchers found that mice lacking PCPE2 had higher levels of good cholesterol (HDL) but still developed similar amounts of artery fat as those without any HDL at all. This matters because it shows that simply having more HDL isn’t enough to prevent heart disease and highlights the importance of PCPE2 in protecting against atherosclerosis. Who this helps: This helps patients at risk for heart disease and doctors treating them.

Plain English
This study looked at how a protein called procollagen C-endopeptidase enhancer 2 affects HDL cholesterol and its role in reducing heart disease risk. Researchers found that this protein helps balance both the production and breakdown of HDL cholesterol in the body, which is important since maintaining healthy cholesterol levels can lower the risk of heart disease. This matters because understanding how this protein works could lead to better ways to manage cholesterol levels and, ultimately, heart disease risk for patients. Who this helps: Patients at risk of cardiovascular disease.

Plain English
This study focused on the role of a protein called lipin-1 in how macrophages (a type of immune cell) respond to modified low-density lipoproteins (LDL) that contribute to atherosclerosis, which can lead to heart disease. Researchers found that reducing lipin-1 levels in macrophages decreased the formation of fatty cells and significantly lowered the production of harmful inflammatory substances by about 70%. These findings are important because they help explain how fat accumulation and inflammation in arteries happen, which can lead to better treatments for cardiovascular disease. Who this helps: Patients at risk of heart disease.

Plain English
Researchers exposed HDL (the "good cholesterol" that normally protects against heart disease) to acrolein, a toxic chemical in cigarette smoke, and found that it damaged the HDL and made it unable to do its job of removing cholesterol from the body. The damaged HDL not only failed to pick up cholesterol from cells but actually caused cholesterol to accumulate inside immune cells instead of being removed. This means smoking damages your good cholesterol so badly that it works backwards—it helps cholesterol build up in your arteries rather than clearing it out, which could explain why smokers have higher heart disease risk despite having HDL in their blood.

Plain English
This study looked at a protein called apolipoprotein M (apoM) and how its increased levels in the liver affect the size and composition of HDL, or "good" cholesterol, in the blood. Researchers found that mice with higher levels of apoM had HDL particles that were about 3-5 times larger than those in normal mice. This is important because larger HDL may help transport beneficial molecules in the body, potentially offering protective effects against heart disease. Who this helps: This research benefits patients at risk for heart disease by exploring the roles of HDL in cholesterol transport and immune function.

Plain English
This study looked at how a specific receptor (scavenger receptor type BI or SR-BI) affects blood cell formation in the context of a disease called atherosclerosis, which involves plaque buildup in arteries. Researchers found that mice lacking SR-BI had more blood stem cells and showed significant increases in numerous blood cell types when fed a high-fat diet, while those with SR-BI responded normally. This matters because it shows that SR-BI is crucial for controlling blood cell production and could influence the way atherosclerosis develops in people. Who this helps: Patients with coronary heart disease.

Plain English
This study looked at how cholesterol moves from different parts of the body to the bloodstream and ultimately gets removed from the body. Researchers found that mice with blocked lymphatic drainage had a significantly reduced ability to move cholesterol from tissues, with one experiment showing that cholesterol transport was impaired despite the presence of leaky blood vessels. These findings are important because they highlight the role of lymphatic vessels in removing cholesterol, which could lead to new treatments for heart disease by improving cholesterol clearance. Who this helps: This helps patients with cardiovascular issues, particularly those dealing with atherosclerosis.

Plain English
This research paper looks at why increasing levels of HDL cholesterol (often called "good" cholesterol) might help prevent heart disease but hasn't worked as hoped with current treatments. The findings show that simply raising HDL levels doesn't necessarily lead to better heart health; instead, the ability of HDL to remove cholesterol from cells is a more important indicator of heart disease risk. This distinction matters because it suggests new ways to approach heart disease treatment that focus on how HDL functions rather than just increasing its quantity. Who this helps: This helps doctors and researchers find better treatments for patients at risk of heart disease.

Plain English
This study examined the structure of a protein called apolipoprotein A-I (apoA-I) when it is not bound to lipids. Researchers found that lipid-free apoA-I has a compact shape made of about four helical regions, where different parts of the protein are closely connected. These findings are important because they help us understand how apoA-I changes shape to pick up lipids, which is crucial for forming healthy cholesterol particles in the body. Who this helps: This research benefits patients at risk for cardiovascular diseases, as it can improve our understanding of cholesterol metabolism.

Plain English
This study looked at a specific genetic mutation in a protein called ApoA-I that is important for cholesterol transport. Researchers found that mice with this mutation developed significantly more atherosclerosis, or cholesterol buildup in arteries, compared to other mice – indicating that these mutated HDL particles do not work properly to remove cholesterol and may actually contribute to heart disease. Specifically, the mice with the mutation had the most cholesterol accumulation in their aorta. Who this helps: This research benefits patients at risk for heart disease, particularly those with genetic factors affecting cholesterol metabolism.

Plain English
This research studied the structure and composition of nascent high-density lipoprotein (nHDL) particles, which are formed in the body and play a role in cholesterol transport. The researchers found that nHDL particles exist in different sizes, with the largest being about 12 nm in diameter and containing around 43% free cholesterol. Understanding how these particles are formed and structured is important because it can help in developing better treatments for heart disease by influencing cholesterol levels in the body. Who this helps: This helps patients at risk for heart disease.

Plain English
This study looked at how high-density lipoprotein (HDL) and a protein called apolipoprotein A-I help manage cholesterol levels and support immune cell function. It found that high levels of HDL are linked to a lower risk of heart disease because they help transport cholesterol from tissues to the liver, and they also have anti-inflammatory effects that can affect immune cells. This is important because it shows how high HDL can not only benefit heart health but also play a role in the immune system. Who this helps: Patients at risk for heart disease and autoimmune conditions.

Plain English
This study looked at how cholesterol-lowering treatments affect immune cells called macrophages in the plaques that form in arteries during heart disease. Researchers found that within two days of treatment, cholesterol levels returned to normal, and after four weeks, the number of macrophages in the plaques dropped by 72%. The key finding was that this decrease in macrophages was due to fewer new monocytes entering the plaques rather than them leaving, which suggests that preventing monocyte entry could be a better way to reduce harmful inflammation in atherosclerosis. Who this helps: This benefits patients with heart disease, particularly those undergoing treatment for high cholesterol.

Plain English
This study looked at a specific version of a protein called apolipoprotein A-I Milano (apoA-I(Milano)), which is different from the common form due to a genetic mutation. Researchers found that apoA-I(Milano) behaves differently than the standard version; it forms pairs of molecules that do not wrap around the fat particles in the same way. They discovered that these pairs change the structure of the particles they are on, which could affect how the body processes fats. Who this helps: This research benefits patients with specific genetic conditions affecting lipid metabolism.

Plain English
This study looked at how a protein called apoA-I affects immune cells in mice that have a genetic setup similar to certain autoimmune diseases. Researchers found that giving these mice injections of apoA-I helped reduce the number of certain immune cells involved in inflammation and increased the regulatory T cells that help control the immune response. Specifically, the treatment led to fewer immune cells in the lymph nodes and reduced fat buildup in tissues, which is important for managing autoimmune conditions. Who this helps: This benefits patients with autoimmune diseases by potentially leading to new treatment options.

Plain English
This study looked at how a high-fat diet affects the immune system in special mice that lack certain proteins. It found that these mice had swollen lymph nodes and spleens and showed increased immune cell activity and production of autoantibodies, which can lead to autoimmune diseases. Treating these mice with a certain virus that delivers a protein called apoA-I helped reduce their symptoms, indicating that apoA-I plays an important role in controlling immune responses related to cholesterol. Who this helps: This helps patients at risk for autoimmune diseases and cardiovascular issues.